002007 Hualan Biological Engineering, Inc.
- 15.76
- -0.02-0.13%
Hualan Biological Engineering, Inc. News
Hualan Biotech: Announcement on the expiration of the period of the chairman, actual controller, some directors, and senior management plans and the completion of the increase in holdings
Hualan Biotech: Announcement on the company\'s acquisition of a single plasma sampling license
Hualan Biotech: Announcement on the Shareholding Company Obtaining an Acceptance Notice for Drug Registration
Hualan Biotech: Announcement on participating companies obtaining drug registration certificates
Hualan Biotech: An indicative announcement on unlocking the listing and circulation of the first restricted shares granted by the 2023 Restricted Stock Incentive Plan
Hualan Biotech: Legal Opinion on matters relating to the fulfillment of the conditions for unlocking the first restricted stocks granted by Hualan Bioengineering Co., Ltd. in the 2023 Restricted Stock Incentive Plan for restricted stocks granted for the first time in the 2023 Restricted Stock Incentive Plan (2)
Hualan Biological Engineering, Inc.: Third-quarter report of 2024.
Hualan Biotech: Announcement of Supervisory Board Resolutions
Hualan Biotech: Announcement of Board Resolutions
Hualan Biotech: Announcement on the achievements of unlocking the conditions for the first time to lift the sales restriction period for restricted stocks granted by the 2023 Restricted Stock Incentive Plan
Hualan Biotech: Announcement on the expiration of reserved rights in the 2023 Stock Incentive Plan
Hualan Biotech: 002007 Hualan Biotech Investor Relations Management Information 20240830
Hualan Biotech: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Hualan Biology: 2024 Semi-Annual Report
Hualan Biology: Summary of the 2024 Semi-Annual Report
Hualan Biological Engineering, Inc.: Notice on the approval of the establishment of a single blood plasma collection station by a wholly-owned subsidiary.
Hualan Biological Engineering, Inc.: Announcement regarding the shareholding of the chairman, actual controller, some directors of the company, as well as the follow-up shareholding plan of the chairman, actual controller, some directors, and senior management personnel.
Hualan Biological Engineering, Inc.: Announcement of Annual Equity Distribution Implementation in 2023
Hualan Biological Engineering, Inc.: Announcement regarding the price adjustment of the main products of the holding subsidiary.
Hualan Biological Engineering, Inc.: Announcement on the company's acquisition of a single plasma sampling license
No Data
